- Research
- 2022-2026 Research Strategy
- Open Clinical Trials
- Closed Clinical Trials
- What is a Clinical Trial?
- Why Participate in a Clinical Trial
- Remote Telehealth Pre-Screening Process
- Research Achievements
- Publications
- Research Development and Funding
- Participating Intitutions
- International Collaboration
- BCT Trials & Projects Summary
- Translational Research
- Clinical Fellowship Program
- International Fellowship Support
- Annual Scientific Meeting
- Travel Grants and Awards
- About
- Our Impact
- Fundraise
- Donate
- Researcher Login
- Cart
Rebranding in 2017
Since its inception in 1978, Breast Cancer Trials has been committed to finding new and improved breast cancer treatments and prevention strategies for every woman, through the conduct of breast cancer clinical trials research. As one of the most successful, respected and oldest breast cancer research groups in the world, our research program has played a pivotal role in influencing and improving breast cancer practice, treatment and care in Australia, New Zealand and globally.
This has been supported by our fundraising department, which has raised more than $80 million for the Breast Cancer Trials research program since 1994, thanks to the generosity of Australian individuals and corporate supporters.
The clinical trials landscape has changed markedly since Breast Cancer Trials formed 40 years ago and we are operating in an increasingly competitive and disruptive research and not-for-profit environment in Australia and New Zealand. For this reason, Breast Cancer Trials embarked on a lengthy and extensive rebranding project with the aim of bringing our two brands together, the Australia and New Zealand Breast Cancer Trials Group (ANZBCTG) and the Breast Cancer Institute of Australia (BCIA), under one name.
Breast Cancer Trials was launched in September 2017. It clearly defines the research we conduct and represents who we are today – a unique collaboration between researchers, clinical trial participants and our supporters. Our logo recognises our place in the world, with a map of Australia and New Zealand, and resembles a fingerprint which speaks to the tailoring of breast cancer treatments to every person and their unique set of circumstances.
So while our name has changed, our commitment to collaborative, high quality breast cancer clinical trials research has not. We are still the same group of world-class professionals based in Australia and New Zealand on a mission for people affected by breast cancer to live better, to live longer, and to never die from breast cancer.
Breast Cancer Trials is grounded and defined by one simple belief: We can and we will find new and better treatments and prevention strategies for every person affected by breast cancer that saves lives today, tomorrow and forever.